ILMN - Illumina, Inc.

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
http://www.illumina.com

SettoreHealthcare
SettoreDiagnostics & Research
Impiegati a tempo pieno7.700

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Jay T. FlatleyExec. Chairman1,26MN/D1953
Mr. Francis A. deSouzaCEO, Pres & DirectorN/DN/D1971
Mr. Sam A. SamadCFO & Sr. VP896,83kN/D1970
Mr. Omead OstadanChief Product & Marketing OfficerN/DN/D1972
Ms. Aimee L. HoytChief People Officer & Sr. VP956,45kN/D1971
Gli importi risalgono al giorno 31 dicembre 2018 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array. It also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. has a collaboration with Roche to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. The company operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, China, and Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Governance aziendale

L'ISS Governance QualityScore di Illumina, Inc. al 3 febbraio 2020 è 5. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 5; diritti degli azionisti: 5; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.
Usando Yahoo accetti che Yahoo e i suoi partners utilizzino cookies per fini di personalizzazione e altre finalità